Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to January 2026, from the company's annual filing with the SEC.
| Salesyearly sales | $15.5B |
| Sales growthchange from the year before | -4.3% |
| Gross marginshare of sales left after the direct cost of what it sells | 40.6% |
| Operating marginshare of sales left after running the business | 4.0% |
| Net marginshare of sales kept as profit | 1.8% |
| Return on invested capitalprofit made on each $100 put into the business | 9.0% |
| Return on equityprofit vs. shareholders' accounting value | 6.7% |
| Debt / equitydebt vs. shareholders' accounting value | 0.35 |
| Change in share countnegative = the company is buying back its shares | +1.8% |
2 insiders sold $759K (all under pre-arranged plans) on the open market.
| Kent Jennifer J.Sr. EVP, CLO & Corp. Sec. | Sold (plan)Aug 3 | 22,942 shat $20.00 · $459K |
| Raymond ChristieSr. EVP, Chief Marketing Off. | Sold (plan)Aug 3 | 15,000 shat $20.00 · $300K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy